Stephen Squinto, Ph.D. is chief investment officer & managing partner at J.P. Morgan Life Sciences Private Capital. Previously an executive partner with OrbiMed, he brings more than 30 years of experience in the biotechnology company building and investing space. He was a co-founder of Alexion Pharmaceuticals, Inc. and served as its executive VP and chief global operations officer. Prior to 2013, he was Alexion’s global head of R&D. While at Alexion, he was responsible for the discovery, development and launch of several successful biotechnology products. From 1988 to 1992, he held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. Stephen is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. He received his B.A. in chemistry and Ph.D. in biochemistry and biophysics from Loyola University of Chicago.